Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Indiana University Bloomington · Indiana University School of Medicine · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
893
total citations
- FWCI
- 81.10
- Percentile
- 100%
- References
- 36
Citations per year
Authors
82- NCNaga ChalasaniCorresponding
Indiana University Bloomington, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis
- HLHerbert L. Bonkovsky
Carolinas Healthcare System
- RJRobert J. Fontana
University of Michigan–Ann Arbor, Ann Arbor Center for Independent Living
- WLWilliam Lee
The University of Texas at Austin, The University of Texas Southwestern Medical Center
- ASAndrew Stolz
University of Southern California
Topics & keywords
Topics
Keywords
- Liver injury
- Drug
- Medicine
- Prospective cohort study
- Internal medicine
- Pharmacology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- UOUniversity of Southern California
- PUPurdue University
- UOUniversity of Pennsylvania
- UOUniversity of Texas Southwestern Medical Center
- GCGeorgia Clinical and Translational Science AllianceAwards: UL1 RR024986, UL1 RR025747, UL1 RR024982, UL1 RR024150, UL1 RR025761, UL1 RR024134
- NINational Institutes of HealthAwards: UL1 RR025761, RR025761, RR024150, UL1 RR024982, RR025747, UL1 RR024986, UL1 RR024134, UL1 RR024150, RR024982, UL1 RR025747
- UOUniversity of California, Los Angeles
- UOUniversity of California, San Francisco
- NCNational Cancer InstituteAward: RR025761
- NINational Institute of Diabetes and Digestive and Kidney DiseasesAwards: DK065211, DK082992, DK065184, DK083020, UL1 RR024150, DK065238, DK065201, UL1 RR025761, DK083023, RR024986, UL1 RR024986, DK083027, UL1 RR024134, U01-DK065184, UL1 RR024982
- DCDuke Clinical Research Institute
- SOSchool of Medicine, University of North Carolina at Chapel Hill